TELA Bio Sees Q1 Sales $18.500M vs $21.277M Est

Benzinga Newsdesk www.benzinga.com Positive 63.5%

Neg 0% Neu 0% Pos 63.5%

TELA Bio (NASDAQ:TELA) sees Q1 sales of $18.500 million vs $21.277 million analyst estimate.

Comments

No comments yet. Be the first!